Clinical Trial Update: Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

View source ↗

Summary

A clinical trial evaluating genomic profiling in previously untreated metastatic non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Cota Inc. | Conditions: Carcinoma, Non-small Cell Lung | Status: TERMINATED